The Effect of Concurrent Stereotactic Body Radiation and Anti-PD-1 Therapy for Recurrent Metastatic Sarcoma-Reference-Cited by-同舟云学术

The Effect of Concurrent Stereotactic Body Radiation and Anti-PD-1 Therapy for Recurrent Metastatic Sarcoma

Published:2020-06-04 Issue:2 Volume:194 Page:124
ISSN:0033-7587
Container-title:Radiation Research
language:
Short-container-title:Radiation Research

Author:

Callaghan Cameron M.¹,Seyedin Steven N.¹,Mohiuddin Imran H.¹,Hawkes Kelli L.¹,Petronek Michael S.¹,Anderson Carryn M.¹,Buatti John M.¹,Milhem Mohammed M.²,Monga Varun²,Allen Bryan G.¹

Affiliation:

1. Department of Radiation Oncology

2. Division of Hematology, Oncology, and Blood and Marrow Transplantation, Holden Comprehensive Cancer Center, Department of Internal Medicine, The University of Iowa, Iowa City, Iowa 52242

Publisher

Radiation Research Society

Subject

Radiology, Nuclear Medicine and imaging,Radiation,Biophysics

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Landmark Series: Multimodal Management of Oligometastatic Sarcoma;Annals of Surgical Oncology;2024-08-30

2. Long Duration Pembrolizumab for Metastatic Undifferentiated Pleomorphic Soft Tissue Sarcoma With Multimodality Therapy;Journal of Medical Cases;2024-07

3. Pembrolizumab and radiation therapy for multifocal myxofibrosarcoma of the scalp: a case report;Therapeutic Advances in Medical Oncology;2024-01

4. A Pilot Study of Pembrolizumab Combined With Stereotactic Ablative Radiotherapy for Patients With Advanced or Metastatic Sarcoma;Cancer Control;2024-01

5. Emerging innovations and advancements in the treatment of extremity and truncal soft tissue sarcomas;Journal of Surgical Oncology;2023-11-27